Fact CheckerSign in

NCT06705413Completed

Effect of Lifestyle Modification on Obese Females With Primary Dysmenorrhea

Source: ClinicalTrials.gov · Last updated 6 May 2026

Brief summary (registry, in English)

The study will be designed to determine the effect of lifestyle modification on primary dysmenorrhea in obese females.

Status (registry)
Completed
Study type
Interventional
Enrollment
67 (actual)
First submitted
22 Nov 2024
Start date
1 Jan 2025
Primary completion date
15 Dec 2025
Lead sponsor
Cairo University
Diseases
Obesity
NCT number
NCT06705413

What you commit to

  • Study type: Interventional
  • Participants enrolled: 67
  • From 1 Jan 2025 to the primary completion date, 15 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Any participant with a history of previous spinal surgeries.

Other illness

  • Any participant with a history of pelvic inflammatory disease, myoma and tumors, pelvic infection, ovarian cyst, any gynecological disease.
  • Any participant with a history of Anemia, diabetes, hypertension, cardiovascular disease, thyroid disease, neurological disorder, rheumatoid arthritis, bariatric surgery, or taking weight loss medication.

Other

  • Any participant having Secondary dysmenorrhea (associated with identifiable pelvic pathology).

Who the study is looking for

  • Young females with moderate to severe primary dysmenorrhea (Visual analogue scale \> 4).
  • Virgin, nonsmokers.
  • Young female aged from 18-25 years with BMI more than 30 kg/m².
  • They have regular menstrual cycles (a menstrual flow of 38 days, with 21-35 days between menstrual flows)
  • They have not practiced sports for at least one year before entering the study.
  • They have not engaged in diet for at least one year before entering the study.

Age in the registry: 18 years to 25 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Noha Taha Abd El-Hamed
Coordinator of this site? Confirm its status
IsmailiaEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.